{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/03/3337449/37519/en/Akebia-Therapeutics-Announces-Initiation-of-a-Phase-2-Basket-Trial-to-Study-Ebribafusp-a-Next-Generation-Complement-Inhibitor-in-Rare-Kidney-Diseases.html", "message": "News view counter 862963 successfully enlarged"}